Hepatology

Hepatology

肝病学

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Hepatology》是由John Wiley and Sons Ltd出版社于1981年创办的英文国际期刊(ISSN: 0270-9139,E-ISSN: 1527-3350),该期刊长期致力于胃肠肝病学领域的创新研究,主要研究方向为医学-胃肠肝病学。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.1540...%),以发表胃肠肝病学领域等方向的原创性研究为核心(研究类文章占比87.10%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在186篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Hepatology审稿周期约为约1.0个月。该刊近年未被列入国际预警名单,年发文量约186篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 186 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 7 / 153

95.8

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 7 / 153

95.75

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 7 / 148

95.6

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 6 / 148

96.28

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 7 / 143

95.5

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 6 / 143

96.15

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:31.2 SJR:7.063 SNIP:4.546
学科类别 分区 排名 百分位
大类:Medicine 小类:Hepatology Q1 5 / 88

94%

期刊发文

  • Lipid nanoparticle-delivered ornithine transcarbamylase mRNA alleviates liver fibrosis in preclinical model

    Author: Zhai, Dongqing; Ni, Jiaping; Shao, Xianyu; Zhao, Weijun; Chen, Yuenan; Fan, Kailin; Li, Jingtong; Shen, Yumeng; Lin, Ang; Hu, Weiwei; Yang, Yong

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001708

  • Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectom

    Author: Zhou, Shi-Qi; Wang, Lu-Na; Wu, Li-Fang; Sun, Li-Yu; Yang, Yu-Chen; Yang, Zi-Yue; Wang, Zi-Yi; He, Tian; Li, Fei; Chen, Ling-Li; Li, Hui; Zhu, Xiao-Dong; Shen, Ying-Hao; Huang, Cheng; Ji, Yuan; Gao, Qiang; Zhou, Jian; Jia, Fan; Chen, Yong-Jun; Song, Tian-Qiang; Xu, Bin; Sun, Hui-Chuan

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001724

  • ECM1 produced by hepatic stellate cells serves as a gatekeeper of liver homeostasis in hepatic fibrosi

    Author: Yang, Aiting; Yan, Xuzhen; Wang, Yiwen; Han, Qi; Tong, Xiaofei; Chen, Shuyan; Zhao, Xinyu; Chen, Wei; Jia, Jidong; Schuppan, Detlef; You, Hong

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001715

  • FYN/LCK kinase balance as a metabolic switch orchestrates progenitor-exhausted T-cell differentiation in hepatocellular carcinom

    Author: Wu, Junyu; Jiang, Zhuofeng; Li, Qiucheng; Cheng, Chien-Shan; Chan, Yau-Tuen; Yeerken, Ranna; Chen, Junbang; Lu, Pengde; Feng, Zixin; Yuan, Hongchao; Xu, Lin; Meng, Zhiqiang; Feng, Yibin; Tan, Hor-Yue; Wang, Ning

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001740

  • Liver transcriptome sequencing contributes to the molecular diagnosis of genetic liver disease

    Author: Cheng, Ye; Li, Zhong-Die; Guan, Zhi-Hong; Wang, Li; Qiu, Yi-Ling; Fang, Wei-Yuan; Zhao, Jing; Zhang, Kun; Li, Jia-Qi; Xing, Qing-He; Wang, Jian-She

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001747

  • Toxic lipid-induced epigenetic activation of ICAM1 in liver sinusoidal endothelium regulates myeloid-driven fibro-inflammatory response in MAS

    Author: Guo, Qianqian; Satthawiwat, Nantawat; Sano, Akitoshi; Meroueh, Chady; Hamdi, Asma; Dai, Xin; Warasnhe, Khaled; Washington, Alexander M.; Starlinger, Patrick P.; Krivonos, Alex; Cao, Sheng; Kostallari, Enis; Jonker, Johan W.; van de Sluis, Bart; Hamdan, Feda H.; Ibrahim, Samar H

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001742

  • Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortiu

    Author: Kanwal, Fasiha; Feng, Ziding; Hoshida, Yujin; Chhatwal, Jagpreet; Wong, Vincent Wai-Sun; Ioannou, George N.; Nahon, Pierre; Lotter, William; Ning, Jing; Taouli, Bachir; Marquez, Guillermo; Fu, Sidney W.; Singal, Amit G

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001745

  • Pathogenic Ifit1+ neutrophils driven by IRF7 promote liver injury and represent a therapeutic target in acute liver failur

    Author: Lu, Yu; Zhang, Yi; Sun, Lina; Gao, Fangyuan; Li, Weiyang; Li, Yanqiu; Zhu, Bingbing; Zeng, Xuanwei; Zhou, Yujia; Feng, Ying; Li, Liying; Wang, Xianbo

    Journal: HEPATOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1097/HEP.0000000000001738